<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40876652</PMID><DateRevised><Year>2025</Year><Month>09</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-2517</ISSN><JournalIssue CitedMedium="Internet"><Volume>392</Volume><PubDate><Year>2025</Year><Month>Aug</Month><Day>26</Day></PubDate></JournalIssue><Title>Journal of affective disorders</Title><ISOAbbreviation>J Affect Disord</ISOAbbreviation></Journal><ArticleTitle>Effects of EMDR vs. waiting list for adults with post-traumatic stress disorder: A systematic review and meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>120134</StartPage><MedlinePgn>120134</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jad.2025.120134</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0165-0327(25)01576-9</ELocationID><Abstract><AbstractText>Posttraumatic Stress Disorder (PTSD) is a prevalent mental health condition that can significantly impair quality of life. Eye Movement Desensitization and Reprocessing (EMDR) has been proposed as a psychotherapeutic intervention for PTSD, yet its effects remain debated. We conducted a systematic review and meta-analysis following PRISMA 2020 guidelines to evaluate EMDR versus waiting list in adults with PTSD. Included RCTs were assessed using the Cochrane Risk of Bias Tool. Random-effects meta-analyses were performed, and evidence certainty was graded using GRADE. Twelve RCTs (n&#xa0;=&#xa0;690 randomized participants) met the inclusion criteria. EMDR may increase the likelihood of losing PTSD diagnosis at post-treatment (Risk Ratio [RR]: 2.13; 95&#xa0;% CI: 1.08-4.23) and follow-up (RR: 3.56; 95&#xa0;% CI: 0.82-15.48), although the evidence is very uncertain. EMDR may also reduce PTSD symptoms at post-treatment (standardized mean difference [SMD]: -1.19; 95&#xa0;% CI: -1.70 to -0.68) and follow-up (SMD: -0.88; 95&#xa0;% CI: -1.62 to -0.13), although evidence certainty remains low to very low. Similar trends were observed for depression, anxiety, social disability, and sleep disturbances, but long-term effects remain unclear. No study assessed relevant outcomes such as quality of life, treatment acceptability, or adverse effects. Risk of bias, particularly due to lack of shielding and allocation concealment, further limits confidence in these findings. Although EMDR may reduce PTSD symptoms and increase the likelihood of diagnostic remission compared to a waiting list, the certainty of the evidence is low to very low, and its long-term effects remain unknown.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Villegas-Ortega</LastName><ForeName>Jose</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Universidad de Ciencias Aplicadas, Lima, Peru; Faculty of System Engineering, Universidad Nacional Mayor de San Marcos, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galvez-Arevalo</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Universidad Peruana Cayetano Heredia, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castilla-Encinas</LastName><ForeName>Adriam M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Sociedad Cient&#xed;fica de San Fernando, Universidad Nacional Mayor de San Marcos, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guti&#xe9;rrez-Gonz&#xe1;lez</LastName><ForeName>Benjam&#xed;n</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Postgraduate Department, Faculty of Medicine, Universidad Nacional Mayor de San Marcos, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Apolitano-C&#xe1;rdenas</LastName><ForeName>Claudia I</ForeName><Initials>CI</Initials><AffiliationInfo><Affiliation>EviSalud - Evidencias en Salud, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alvarez-Arias</LastName><ForeName>Priscilla</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>EviSalud - Evidencias en Salud, Lima, Peru; Universidad Nacional Mayor de San Marcos, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paredes-Angeles</LastName><ForeName>Rub&#xed;</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Universidad Cient&#xed;fica del Sur, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taype-Rondan</LastName><ForeName>Alvaro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>EviSalud - Evidencias en Salud, Lima, Peru; Unidad de Investigaci&#xf3;n para la Generaci&#xf3;n y S&#xed;ntesis de Evidencia en Salud, Vicerrectorado de Investigaci&#xf3;n, Universidad San Ignacio de Loyola, Lima, Peru. Electronic address: alvaro.taype.r@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Affect Disord</MedlineTA><NlmUniqueID>7906073</NlmUniqueID><ISSNLinking>0165-0327</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EMDR</Keyword><Keyword MajorTopicYN="N">Eye movement desensitization and reprocessing</Keyword><Keyword MajorTopicYN="N">PSTD</Keyword><Keyword MajorTopicYN="N">Posttraumatic stress disorder</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword><Keyword MajorTopicYN="N">Trauma-focused psychotherapy</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare no conflicts of interest regarding the present study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>29</Day><Hour>0</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>29</Day><Hour>0</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>28</Day><Hour>19</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40876652</ArticleId><ArticleId IdType="doi">10.1016/j.jad.2025.120134</ArticleId><ArticleId IdType="pii">S0165-0327(25)01576-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>